NCT06223971 - Long COVID-19 [11C]CPPC Study | Biotech Hunter

Enrollment

6

Participants

Timeline

Start Date

August 6, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

September 30, 2025

Conditions

COVID Long-Haul

Interventions

DRUG

[11C]CPPC Injection

"A single dose of \[11C\]CPPC (370 megabecquerel (MBq) (X±1 mCi)) intravenously and subsequent positron emission tomography (PET) scan.~Other Name: \[5-cyano-N-(4-(4-\[11C\]methylpiperazin-1-yl)-2-(piperidin-1-yl)phenyl)furan-2-carboxamide\]"

DRUG

[11C]CPPC Injection

"A single dose of \[11C\]CPPC (370 megabecquerel (MBq) (X±1 mCi)) intravenously and subsequent positron emission tomography (PET) scan.~Other Name: \[5-cyano-N-(4-(4-\[11C\]methylpiperazin-1-yl)-2-(piperidin-1-yl)phenyl)furan-2-carboxamide\]"

Trial Locations (1)

21287

Johns Hopkins Outpatient Center, Baltimore